Good Day BIO Newsletter Archive | January 5, 2024
Writing in The Hill, BIO’s Chief Policy Officer John Murphy explains how IP enables innovation and access to COVID technology. Meanwhile, BIO has joined an amicus brief against a lawsuit that questions a drug company’s decisions about the pace of drug development. (481 words, 2 minutes, 24 seconds)